Skip to content

MASS

908 Devices Inc.

NASDAQ · USHealthcareMedical - Devices
$7.03-4.35%

Price as of Jul 20, 2026

MASS growth

908 Devices Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+2.2%
EBITDA
+8.4%
EBIT
+52.8%
EPS
-78.2%
Free cash flow
+76.5%
Operating cash flow
+78.9%

Forward estimates

Revenue
-37.9%
EBITDA
+21.8%
EPS
+93.7%

Three-year CAGR

Revenue
+6.2%
EBITDA
+34.2%
EBIT
+68.5%
Net income
+49.3%
EPS
+125.5%
Free cash flow
+20.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.